SCHEMBL24469717

SCHEMBL24469717

CCc1cccc(NC(=O)c2c(Br)ccc3c2OCO3)c1C(=O)C(C)CC

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
MAPT P10636 3/20 0.36
KMT2A Q03164 4/20 0.36
PTGS2 P35354 1/20 0.35
MEN1 O00255 3/20 0.34
ALDH1A1 P00352 2/20 0.34
POLB P06746 2/20 0.34
CYP1A2 P05177 2/20 0.34
CYP3A4 P08684 2/20 0.34
CYP2D6 P10635 2/20 0.34
CYP2C19 P33261 2/20 0.34
MAPK1 P28482 1/20 0.34
CYP2C9 P11712 1/20 0.34
KDM4E B2RXH2 1/20 0.34
LMNA P02545 1/20 0.34
HPGD P15428 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
MT-CO2 P00403 1/20 0.34
DRD2 P14416 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10132867 0.70 MAPT (0.47) NPC1RAB9AMAPTKMT2AMEN1
SCHEMBL13485804 0.70 AOC3 (0.46) NPC1RAB9AMAPTKMT2AMEN1
SCHEMBL27164937 0.66 MAPK1 (0.39) NPC1RAB9AMAPTKMT2APTGS2
SCHEMBL27967472 0.65 AOC3 (0.50) NPC1RAB9AMAPTKMT2AMEN1
SCHEMBL8470586 0.65 AOC3 (0.44) NPC1RAB9AMAPTKMT2AMEN1
SCHEMBL423788 0.64 AOC3 (0.49) NPC1RAB9AMAPTKMT2AMEN1
SCHEMBL422232 0.63 AOC3 (0.47) NPC1RAB9AMAPTKMT2AMEN1
SCHEMBL12071539 0.63 AOC3 (0.47) NPC1RAB9AMAPTKMT2AMEN1
SCHEMBL26054366 0.62 AOC3 (0.44) NPC1RAB9AMAPTKMT2AMEN1
SCHEMBL24469687 0.62 KMT2A (0.51) MAPTKMT2AMEN1ALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022115301-A1 MODIFIED ISOINDOLINONES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS MERCK SHARP & DOHME CORP. (US) 2022-06-02 WO disclosed